Volitionrx (VNRX) Capital Leases (2018 - 2025)

Volitionrx (VNRX) posted Capital Leases of $317859.0 for Q4 2025, down 4.13% on a QoQ basis from $331550.0 in Q3 2025, and down 3.19% year-over-year from $328338.0 in Q4 2024.

Volitionrx (VNRX) Capital Leases (2018 - 2025) Analysis & Trends

Volitionrx's Capital Leases history runs 8 years deep, the most recent figure standing at $317859.0 for Q4 2025.

  • Quarterly Capital Leases fell 3.19% year-over-year to $317859.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $317859.0 (down 3.19% YoY) and the FY2025 annual result came in at $317859.0, down 3.19% from the prior year.
  • Capital Leases was $317859.0 for Q4 2025 at Volitionrx, down from $331550.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $557338.0 in Q2 2021 and bottomed at $317859.0 in Q4 2025.
  • A 5-year average of $409979.9 and a median of $400022.0 in 2023 frame the typical range for Capital Leases.
  • Annual changes were most pronounced in 2022 — Capital Leases declined 23.29% — and 2023, when it retreated 3.17%.
  • Volitionrx's Capital Leases stood at $511086.0 in 2021, then slipped by 14.67% to $436132.0 in 2022, then declined by 8.28% to $400022.0 in 2023, then retreated by 17.92% to $328338.0 in 2024, then decreased by 3.19% to $317859.0 in 2025.
  • Business Quant data shows VNRX's Capital Leases at $317859.0 in Q4 2025, $331550.0 in Q3 2025, and $346291.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Volitionrx 109,643.10 -2.35 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 317,859.00
Sep 30, 2025 331,550.00
Jun 30, 2025 346,291.00
Mar 31, 2025 330,847.00
Dec 31, 2024 328,338.00
Sep 30, 2024 366,175.00
Jun 30, 2024 363,927.00
Mar 31, 2024 379,667.00
Dec 31, 2023 400,022.00
Sep 30, 2023 395,390.00
Jun 30, 2023 419,804.00
Mar 31, 2023 429,977.00
Dec 31, 2022 436,132.00
Sep 30, 2022 408,344.00
Jun 30, 2022 447,880.00
Mar 31, 2022 486,690.00
Dec 31, 2021 511,086.00
Sep 30, 2021 532,301.00
Jun 30, 2021 557,338.00
Dec 31, 2020 601,967.00